Sign in
Taking people in NorwayPhase 2/3

Oxygen in a pressure chamber added to usual care for sudden hearing loss

Tests whether pressure-chamber oxygen plus usual care improves hearing in adults with sudden hearing loss.

Key facts

Who runs it
Helse Bergen HF
Where
Aalesund, Bergen, Drammen, Foerde, Gjoevik, Graalum, Kristiansand S, Loerenskog, Oslo, Skien, Stavanger, and Trondheim, NorwaySee the 12 sites
Registry title
Efficacy of Hyperbaric oxygen in addition to standard treatment for acute sudden deafness
Status
Recruiting
Phase
Phase 2/3
People taking part
490 people, planned
Started
28 Jan 2022
Expected to end
30 Sept 2028
Type of study
Interventional
Record updated
6 November 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with sudden hearing loss in the inner ear that has no known cause. It tests hyperbaric oxygen (breathing pure oxygen in a pressure chamber) added to standard care.

Age
18 to 80 years
Sex
All sexes can join.
Disease stage
Hearing loss started no more than 7 days ago, and oxygen treatment can start within 7 days of the first symptoms. A hearing test shows at least 30dB loss in three frequencies in a row, and an average hearing threshold of 50 dB or more.
Earlier treatment
People who ever had Bleomycin cannot join. People now taking Disulfiram (Antabus ®) cannot join.
Biomarker or test result
Pure tone audiometry (a hearing test) must show inner ear hearing loss as described above.

Main reasons for not taking part

  • Hearing loss most likely caused by another disease, injury or condition
  • Serious lung disease (such as FEV1 <50% of expected), poorly controlled asthma, or pneumonia now or less than 4 weeks ago
  • Severe heart failure, unstable angina, or heart attack less than 6 months ago
  • Artificial middle ear bones, or pregnancy
  • Major alcohol abuse, or memory, thinking or language problems that make it hard to follow the study

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • 18 to 80 years of age
  • Onset of acute hearing loss no longer than 7 days ago
  • HBO can be started within 7 days from symptom onset
  • Pure tone audiometry shows sensorineural hearing loss with at least 30dB loss in three consecutive frequencies
  • Idiopathic sensorineural hearing loss is the most probable diagnosis according to clinical judgement
  • The hearing threshold is 50 dB or more in PTA (based on 0,5kHz, 1kHz, 2kHz, 4kHz)

Who cannot take part

  • Any contraindication to treatment with hyperbaric oxygen: - COPD, asthma or other lung disease with severely reduced lung function corresponding to GOLD III (spirometry shows FEV1 <50% of expected) - Asthma not well regulated on oral basic medication and/or with attacks within the last year - Current pneumonia or <4 weeks from complete recovery - X-ray showing emphysema-bulla or non-static atelectasis - Severe cardiac failure, instable angina, cardial infarction <6 months ago - Ongoing use of Disulfiram (Antabus ®) - Earlier treatment with Bleomycin (any time) - Artificial middle ear bones - Pregnancy
  • Not idiopathic sudden sensorineural hearing loss, but another disease, injury or condition is most likely the cause of the current hearing loss
  • Cognitive or language barriers that hamper adherence to the study protocol 3. Major
  • Major alcohol abuse

Where in Norway

  • Helse Moere Og Romsdal HFAalesund, NorwayTaking people
  • Helse Bergen HFBergen, NorwayTaking people
  • Drammen SykehusDrammen, NorwayTaking people
  • Helse Forde HFFoerde, NorwayTaking people
  • Sykehuset Innlandet HFGjoevik, NorwayTaking people
  • Sykehuset Oestfold HF KalnesGraalum, NorwayTaking people
  • Sorlandet Sykehus HFKristiansand S, NorwayTaking people
  • Akershus University HospitalLoerenskog, NorwayTaking people
  • Oslo University Hospital HFOslo, NorwayTaking people
  • Sykehuset Telemark HFSkien, NorwayTaking people
  • Helse Stavanger HFStavanger, NorwayTaking people
  • St. Olavs hospital HFTrondheim, NorwayTaking people

About the trial

What the trial wants to find out

To assess if the addition of HBOT to standard care leads to better hearing 3 months after treatment than treatment with standard care only.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
Official title
Hyperbaric oxygen treatment added to standard care for acute idiopathic sudden sensorineural hearing loss - a multicentre randomized controlled trial
Plain-language title
Oxygen in a pressure chamber added to usual care for sudden hearing lossGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
6 November 2026